Jennison Associates LLC Alkermes Plc. Transaction History
Jennison Associates LLC
- $155 Billion
- Q2 2024
A detailed history of Jennison Associates LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Jennison Associates LLC holds 54,488 shares of ALKS stock, worth $1.54 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,488
Previous 45,371
20.09%
Holding current value
$1.54 Million
Previous $1.23 Million
6.92%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ALKS
# of Institutions
350Shares Held
183MCall Options Held
209KPut Options Held
89.4K-
Black Rock Inc. New York, NY29.1MShares$823 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$565 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.4MShares$406 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11MShares$311 Million0.03% of portfolio
-
State Street Corp Boston, MA9.22MShares$261 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.64B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...